These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38286828)

  • 1. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma.
    Mahmood M; Liu EM; Shergold AL; Tolla E; Tait-Mulder J; Huerta-Uribe A; Shokry E; Young AL; Lilla S; Kim M; Park T; Boscenco S; Manchon JL; Rodríguez-Antona C; Walters RC; Springett RJ; Blaza JN; Mitchell L; Blyth K; Zanivan S; Sumpton D; Roberts EW; Reznik E; Gammage PA
    Nat Cancer; 2024 Apr; 5(4):659-672. PubMed ID: 38286828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade.
    Mahmood M; Liu EM; Shergold AL; Tolla E; Tait-Mulder J; Huerta Uribe A; Shokry E; Young AL; Lilla S; Kim M; Park T; Manchon JL; Rodríguez-Antona C; Walters RC; Springett RJ; Blaza JN; Zanivan S; Sumpton D; Roberts EW; Reznik E; Gammage PA
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids.
    McKenzie M; Duchen MR
    PLoS One; 2016; 11(4):e0154371. PubMed ID: 27110715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.
    Järviaho T; Hurme-Niiranen A; Soini HK; Niinimäki R; Möttönen M; Savolainen ER; Hinttala R; Harila-Saari A; Uusimaa J
    Clin Genet; 2018 Feb; 93(2):275-285. PubMed ID: 28708239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
    Park JS; Sharma LK; Li H; Xiang R; Holstein D; Wu J; Lechleiter J; Naylor SL; Deng JJ; Lu J; Bai Y
    Hum Mol Genet; 2009 May; 18(9):1578-89. PubMed ID: 19208652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness and promotes the selection of wild-type over mutant mitochondrial DNA.
    Pantic B; Ives D; Mennuni M; Perez-Rodriguez D; Fernandez-Pelayo U; Lopez de Arbina A; Muñoz-Oreja M; Villar-Fernandez M; Dang TJ; Vergani L; Johnston IG; Pitceathly RDS; McFarland R; Hanna MG; Taylor RW; Holt IJ; Spinazzola A
    Nat Commun; 2021 Dec; 12(1):6997. PubMed ID: 34873176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
    Hashimoto M; Bacman SR; Peralta S; Falk MJ; Chomyn A; Chan DC; Williams SL; Moraes CT
    Mol Ther; 2015 Oct; 23(10):1592-9. PubMed ID: 26159306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA mutations and breast tumorigenesis.
    Yadav N; Chandra D
    Biochim Biophys Acta; 2013 Dec; 1836(2):336-44. PubMed ID: 24140413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
    Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
    J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.
    Philley JV; Kannan A; Qin W; Sauter ER; Ikebe M; Hertweck KL; Troyer DA; Semmes OJ; Dasgupta S
    J Cell Physiol; 2016 Jun; 231(6):1364-74. PubMed ID: 26530043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption.
    McKenzie M; Liolitsa D; Akinshina N; Campanella M; Sisodiya S; Hargreaves I; Nirmalananthan N; Sweeney MG; Abou-Sleiman PM; Wood NW; Hanna MG; Duchen MR
    J Biol Chem; 2007 Dec; 282(51):36845-52. PubMed ID: 17940288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.
    Blok MJ; Spruijt L; de Coo IF; Schoonderwoerd K; Hendrickx A; Smeets HJ
    J Med Genet; 2007 Apr; 44(4):e74. PubMed ID: 17400793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).
    Jiménez-Morales S; Pérez-Amado CJ; Langley E; Hidalgo-Miranda A
    Int J Oncol; 2018 Sep; 53(3):923-936. PubMed ID: 30015870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-replicative recombinant 5S rRNA molecules can modulate the mtDNA heteroplasmy in a glucose-dependent manner.
    Loutre R; Heckel AM; Jeandard D; Tarassov I; Entelis N
    PLoS One; 2018; 13(6):e0199258. PubMed ID: 29912984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
    Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
    Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexities and pitfalls in analyzing and interpreting mitochondrial DNA content in human cancer.
    Nguyen H; LaFramboise T
    J Genet Genomics; 2020 Jul; 47(7):349-359. PubMed ID: 33004308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rewiring cell signalling pathways in pathogenic mtDNA mutations.
    Chung CY; Valdebenito GE; Chacko AR; Duchen MR
    Trends Cell Biol; 2022 May; 32(5):391-405. PubMed ID: 34836781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging-associated mitochondrial DNA mutations alter oxidative phosphorylation machinery and cause mitochondrial dysfunctions.
    Li H; Shen L; Hu P; Huang R; Cao Y; Deng J; Yuan W; Liu D; Yang J; Gu H; Bai Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2266-2273. PubMed ID: 28559044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.
    Iommarini L; Kurelac I; Capristo M; Calvaruso MA; Giorgio V; Bergamini C; Ghelli A; Nanni P; De Giovanni C; Carelli V; Fato R; Lollini PL; Rugolo M; Gasparre G; Porcelli AM
    Hum Mol Genet; 2014 Mar; 23(6):1453-66. PubMed ID: 24163135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.